BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21824654)

  • 1. Pneumocystis jirovecii pneumonia as a complication of bendamustine in a patient receiving bendamustine plus rituximab for marginal zone lymphoma.
    Carter SJ; Bernstein SH; Friedberg JW; Barr PM
    Leuk Res; 2011 Nov; 35(11):e223-4. PubMed ID: 21824654
    [No Abstract]   [Full Text] [Related]  

  • 2. The incidence of Pneumocystis jirovecii pneumonia is not higher in patients receiving dose-dense therapy with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine, and prednisolone and adequate Pneumocystis jirovecii pneumonia prophylaxis.
    Isidori A; Merli F; Angrilli F; Ferrara F; Alesiani F; Visani G
    Leuk Lymphoma; 2011 Jan; 52(1):148-9. PubMed ID: 21067442
    [No Abstract]   [Full Text] [Related]  

  • 3. A resurgence of Pneumocystis in aggressive lymphoma treated with R-CHOP-14: the price of a dose-dense regimen?
    Tadmor T; McLaughlin P; Polliack A
    Leuk Lymphoma; 2010 May; 51(5):737-8. PubMed ID: 20367567
    [No Abstract]   [Full Text] [Related]  

  • 4. A unique description of stage IV extranodal marginal zone lymphoma (EMZL) in an adolescent associated with gamma heavy chain disease.
    Mittal N; Zhu B; Gaitonde S; Lu Y; Schmidt ML
    Pediatr Blood Cancer; 2015 May; 62(5):905-8. PubMed ID: 25663537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three cases of Pneumocystis jirovecii pneumonia (PCP) during first-line treatment with rituximab in combination with CHOP-14 for aggressive B-cell non-Hodgkin's lymphoma.
    Venhuizen AC; Hustinx WN; van Houte AJ; Veth G; van der Griend R
    Eur J Haematol; 2008 Mar; 80(3):275-6. PubMed ID: 18005387
    [No Abstract]   [Full Text] [Related]  

  • 6. Rituximab plus bendamustine is active in pretreated patients with extragastric marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma).
    Kiesewetter B; Mayerhoefer ME; Lukas J; Zielinski CC; Müllauer L; Raderer M
    Ann Hematol; 2014 Feb; 93(2):249-53. PubMed ID: 23925930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High incidence of Pneumocystis jirovecii pneumonia in patients receiving biweekly rituximab and cyclophosphamide, adriamycin, vincristine, and prednisone.
    Kamel S; O'Connor S; Lee N; Filshie R; Nandurkar H; Tam CS
    Leuk Lymphoma; 2010 May; 51(5):797-801. PubMed ID: 20367135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma.
    Ogura M; Ando K; Taniwaki M; Watanabe T; Uchida T; Ohmachi K; Matsumoto Y; Tobinai K;
    Cancer Sci; 2011 Sep; 102(9):1687-92. PubMed ID: 21624007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.
    Rummel MJ; Niederle N; Maschmeyer G; Banat GA; von Grünhagen U; Losem C; Kofahl-Krause D; Heil G; Welslau M; Balser C; Kaiser U; Weidmann E; Dürk H; Ballo H; Stauch M; Roller F; Barth J; Hoelzer D; Hinke A; Brugger W;
    Lancet; 2013 Apr; 381(9873):1203-10. PubMed ID: 23433739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous occurrence of large B-cell non-Hodgkin lymphoma and acute myeloid leukaemia in an elderly patient: complete remissions of both diseases by rituximab-bendamustine regimen combined to hypomethylating therapy.
    Palombi M; Niscola P; Tendas A; Trawinska MM; Scaramucci L; Giovannini M; Fratoni S; Perrotti A; de Fabritiis P
    J Chemother; 2013 Aug; 25(4):247-9. PubMed ID: 23906078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare presentation of secondary cutaneous involvement by splenic marginal zone lymphoma: report of a case and review of the literature.
    Cohen JM; Nazarian RM; Ferry JA; Takvorian RW; Carter JB
    Am J Dermatopathol; 2015 Jan; 37(1):e1-4. PubMed ID: 25238446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine use of bendamustine and rituximab combination therapy in consecutive patients with lymphoproliferative diseases: a survey from Tyrolean hospitals.
    Waldthaler C; Stauder R; Schnallinger M; Schreieck S; Hager J; Oexle H; Zangerl G; Verdorfer I; Zabernigg A; Gastl G; Fiegl M
    Wien Klin Wochenschr; 2011 May; 123(9-10):269-75. PubMed ID: 21479652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The increased risk for pneumocystis pneumonia in patients receiving rituximab-CHOP-14 can be prevented by the administration of trimethoprim/sulfamethoxazole: a single-center experience.
    Hardak E; Oren I; Dann EJ; Yigla M; Faibish T; Rowe JM; Avivi I
    Acta Haematol; 2012; 127(2):110-4. PubMed ID: 22178955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolution of granuloma annulare following treatment with bendamustine and rituximab in a patient with follicular lymphoma: a serendipitous finding.
    Shah BK; Hewett Y; Peterson A; Tretheway D
    J Postgrad Med; 2014; 60(4):406-8. PubMed ID: 25370553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of rituximab plus bendamustine for gastric marginal zone lymphoma.
    Cencini E; Fabbri A; Schiattone L; Bocchia M
    Leuk Lymphoma; 2019 Mar; 60(3):833-835. PubMed ID: 30234387
    [No Abstract]   [Full Text] [Related]  

  • 16. Bendamustine in chronic lymphocytic leukemia: the future is combination therapy.
    Friedberg JW
    Leuk Lymphoma; 2009 Sep; 50(9):1399-400. PubMed ID: 19811324
    [No Abstract]   [Full Text] [Related]  

  • 17. Two cases of Pneumocystis jiroveci pneumonia with non-Hodgkin's lymphoma after CHOP-based chemotherapy containing rituximab.
    Kurokawa T; Kaya H; Yoshida T
    J Clin Exp Hematop; 2010; 50(2):159-62. PubMed ID: 21123974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recommendation for the optimal use of bendamustine in Japan].
    Ohmachi K; Maruyama D; Nisikori M; Suzuki T; Izutsu K
    Rinsho Ketsueki; 2014 Mar; 55(3):311-20. PubMed ID: 24681934
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyperhemolysis associated with marginal zone lymphoma.
    Yan M; Callum J; Lin Y
    Leuk Lymphoma; 2015 Mar; 56(3):829-31. PubMed ID: 24991717
    [No Abstract]   [Full Text] [Related]  

  • 20. Making advances in first-line chronic lymphocytic leukemia treatment.
    Wierda WG
    J Clin Oncol; 2012 Sep; 30(26):3162-4. PubMed ID: 22869876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.